Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Biochimica Et Biophysica Acta
|
July 10, 1979
Tetanus relaxation. Temperature effects and Arrhenius analysis
A Sandow, R J Zeman
Annals of the New York Academy of Sciences
|
January 1, 1979
Denervation effects on dystrophic and normal muscles and the etiology of dystrophy
R J Zeman, A Sandow
Brain Research
|
July 11, 1994
Protein phosphatase inhibitors prolong Ca(2+)-transients and divalent cation-dependent action potentials in leech Retzius cells
A L Kleinhaus, R J Zeman
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 1, 1980
Correlative histochemical and physiological measurements in single skinned muscle fibers: Heterogeneity of Ca sensitivity in type I fibers
R J Zeman, D S Wood
The American Journal of Physiology
|
September 1, 1994
Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle
R J Zeman, Y Zhang, J D Etlinger
The American Journal of Physiology
|
April 1, 1997
Clenbuterol, a beta2-adrenoceptor agonist, reduces scoliosis due to partial transection of rat spinal cord
R J Zeman, Y Zhang, J D Etlinger
Experimental Neurology
|
April 17, 2026
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury
L K Friedman, R J Zeman, H Peng
The American Journal of Physiology
|
January 1, 1987
Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles
R J Zeman, R Ludemann, J D Etlinger
Experimental Neurology
|
August 24, 2021
Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury
L K Friedman, H Peng, R J Zeman
Experimental Neurology
|
September 16, 1999
Clenbuterol, a beta(2)-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats
R J Zeman, Y Feng, H Peng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Biochimica Et Biophysica Acta
|
July 10, 1979
Tetanus relaxation. Temperature effects and Arrhenius analysis
A Sandow, R J Zeman
Annals of the New York Academy of Sciences
|
January 1, 1979
Denervation effects on dystrophic and normal muscles and the etiology of dystrophy
R J Zeman, A Sandow
Brain Research
|
July 11, 1994
Protein phosphatase inhibitors prolong Ca(2+)-transients and divalent cation-dependent action potentials in leech Retzius cells
A L Kleinhaus, R J Zeman
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 1, 1980
Correlative histochemical and physiological measurements in single skinned muscle fibers: Heterogeneity of Ca sensitivity in type I fibers
R J Zeman, D S Wood
The American Journal of Physiology
|
September 1, 1994
Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle
R J Zeman, Y Zhang, J D Etlinger
The American Journal of Physiology
|
April 1, 1997
Clenbuterol, a beta2-adrenoceptor agonist, reduces scoliosis due to partial transection of rat spinal cord
R J Zeman, Y Zhang, J D Etlinger
Experimental Neurology
|
April 17, 2026
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury
L K Friedman, R J Zeman, H Peng
The American Journal of Physiology
|
January 1, 1987
Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles
R J Zeman, R Ludemann, J D Etlinger
Experimental Neurology
|
August 24, 2021
Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury
L K Friedman, H Peng, R J Zeman
Experimental Neurology
|
September 16, 1999
Clenbuterol, a beta(2)-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats
R J Zeman, Y Feng, H Peng, et al.
Page
of 2